HTGMQ (HTG Molecular Diagnostics) Quick Ratio: 1.30 (As of Mar. 2023)


HTGMQ HTG Molecular Diagnostics Inc HTGMQ
12 GF Score
Price $0.00
View Full Analysis

What is HTG Molecular Diagnostics Quick Ratio?

HTG Molecular Diagnostics HTGMQ 12 Quick Ratio is 1.30 as of Mar. 2023. GuruFocus rates HTGMQ with a GF Score™ of 12/100.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. HTG Molecular Diagnostics's quick ratio for the quarter that ended in Mar. 2023 was 1.30.

HTG Molecular Diagnostics has a quick ratio of 1.30. It generally indicates good short-term financial strength.

The historical rank and industry rank for HTG Molecular Diagnostics's Quick Ratio or its related term are showing as below:

HTGMQ's Quick Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.69
* Ranked among companies with meaningful Quick Ratio only.

HTG Molecular Diagnostics  (OTCPK:HTGMQ) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


HTG Molecular Diagnostics Quick Ratio Related Terms


HTG Molecular Diagnostics Quick Ratio Historical Data

* Premium members only.

The historical data trend for HTG Molecular Diagnostics's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HTG Molecular Diagnostics Quick Ratio Chart

HTG Molecular Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.22 4.51 4.34 2.53 1.78

HTG Molecular Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 1.71 1.33 1.78 1.30

HTGMQ vs ABMC, TMO, DHR: Quick Ratio Comparison

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HTG Molecular Diagnostics Quick Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Quick Ratio distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Quick Ratio falls into.


HTGMQ
12GF Score
HTG Molecular Diagnostics Inc HTGMQ
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HTG Molecular Diagnostics Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

HTG Molecular Diagnostics's Quick Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Quick Ratio (A: Dec. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(15.651-0.909)/8.271
=1.78

HTG Molecular Diagnostics's Quick Ratio for the quarter that ended in Mar. 2023 is calculated as

Quick Ratio (Q: Mar. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(9.187-0.655)/6.559
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 1.30 mean?
HTG Molecular Diagnostics (HTGMQ) has a Quick Ratio of 1.30 as of Mar. 2023. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on HTG Molecular Diagnostics and its competitors.
Is HTG Molecular Diagnostics' Quick Ratio too high?
HTG Molecular Diagnostics' current Quick Ratio is 1.30. The Medical Diagnostics & Research industry median Quick Ratio is 1.69. HTG Molecular Diagnostics' value of 1.30 is 23.1% below this industry median. Overall, HTG Molecular Diagnostics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HTG Molecular Diagnostics' Quick Ratio compare to ABMC and TMO?
HTG Molecular Diagnostics' Quick Ratio of 1.30 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Quick Ratio is 1.69. HTG Molecular Diagnostics' value of 1.30 is 23.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.69, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HTG Molecular Diagnostics's current Quick Ratio of 1.30 is 23.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on HTG Molecular Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HTG Molecular Diagnostics's current Quick Ratio is 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HTG Molecular Diagnostics stock overvalued right now?
HTG Molecular Diagnostics (HTGMQ) has a current Quick Ratio of 1.30. The current Quick Ratio is 1.30 and 23.1% below the Medical Diagnostics & Research industry median of 1.69. HTG Molecular Diagnostics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For HTG Molecular Diagnostics (HTGMQ), the current Quick Ratio is 1.30 as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HTG Molecular Diagnostics Business Description

Address 3430 E. Global Loop, Tucson, AZ, USA, 85706
HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.
12GF Score

Get the complete analysis for HTGMQ

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price